Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole. (Q47425844)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

title

Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

Nicolas Hohmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

Gerd Mikus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Franziska Kocheise

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

Alexandra Carls

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

Jürgen Burhenne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

Johanna Weiss

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

publication date

1 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

1535-1545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

The human intestinal cytochrome P450 "pie".

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Concentration effect relationship of CYP3A inhibition by ritonavir in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Combination of capecitabine and phenytoin may cause phenytoin intoxication: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40262-016-0416-1

Phenytoin: Pharmacokinetics and bioavailability

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27236320

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Route of Administration and Drug Disposition

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27236320

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27236320

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40262-016-0416-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27236320 AND SRC:MED&resulttype=core&format=json

3 April 2020

1 reference